8 Things to Know About Using Ashwagandha Correctly During Menopause
Ashwagandha was one of the first supplements that actually made a noticeable difference — but it took a few wrong starts to get there. The first version tried was a cheap powder that seemed to do nothing, and it wasn't until switching to a standardised root extract at the right dose that sleep and that relentless low-grade anxiety started to shift. The details really do matter with this one.
Learn more about Rose →The extract form matters far more than the label claim
Not all ashwagandha products are equivalent. The clinical trials showing benefits for stress, cortisol, and sleep have almost exclusively used standardised root extracts — particularly KSM-66 and Sensoril — which are concentrated to contain specific levels of active compounds called withanolides, typically 5% or higher. A generic ashwagandha powder or capsule with no standardisation information on the label is unlikely to deliver the doses of active compounds used in research, regardless of what the marketing says.
The research-backed dose is narrower than most products suggest
Studies finding meaningful reductions in perceived stress, cortisol levels, and sleep latency in adults have generally used between 300mg and 600mg of standardised root extract per day. Some trials have used up to 600mg twice daily for specific outcomes, but there is no evidence that higher doses produce better results — and going well beyond 600mg daily increases the risk of gastrointestinal side effects and potential liver stress. Many off-the-shelf products are dosed either too low to be effective or encourage unnecessarily high intake.
It takes four to eight weeks to work — results are not immediate
Ashwagandha is an adaptogen, meaning it works by modulating the body's stress response systems over time rather than producing an acute effect like a sedative or stimulant. Clinical trials consistently show that measurable changes in cortisol, self-reported anxiety, and sleep quality emerge at the four-week mark and are more pronounced at eight to twelve weeks. Women who try it for a week and conclude it is not working are almost certainly drawing a conclusion too early.
Timing and food pairing genuinely affect how well it is tolerated
Taking ashwagandha on an empty stomach is a common reason women experience nausea and abandon it — the withanolides are better absorbed and far less likely to cause gastric irritation when taken with food. For women primarily using it to support sleep, taking the dose with the evening meal or shortly before bed aligns with the research and allows the mild calming effect to coincide with the wind-down period. For general stress and cortisol support, splitting the dose between morning and evening meals is the approach used in most successful trials.
It has a real interaction with thyroid medication that is frequently overlooked
Ashwagandha has been shown in human trials to increase levels of thyroid hormones T3 and T4, which is significant because hypothyroidism is already more common in perimenopausal and menopausal women, and many are already on levothyroxine or similar medication. Adding ashwagandha without telling a prescribing doctor can shift thyroid levels enough to require a medication adjustment, or to produce symptoms of mild hyperthyroidism — palpitations, anxiety, and disrupted sleep — which are easily mistaken for menopause symptoms themselves. Anyone on thyroid medication should have levels checked before starting and again after six to eight weeks.
There is a rare but documented risk of liver injury that deserves honest attention
Several case reports have linked ashwagandha use to cholestatic liver injury — a condition where bile flow from the liver is impaired — typically emerging within one to four months of starting. The risk appears low and may be idiosyncratic (an unpredictable individual reaction rather than a dose-dependent toxic effect), but it is real enough that anyone with pre-existing liver conditions, who drinks alcohol regularly, or who is taking other supplements or medications that stress the liver should discuss this with a doctor before starting. Unexplained fatigue, yellowing of the skin or eyes, or dark urine while taking ashwagandha should prompt stopping it and getting liver function tested promptly.
It should not be combined with sedative medications without medical guidance
Ashwagandha has GABAergic activity — meaning it acts on the same calming neurotransmitter pathway that benzodiazepines, sleep medications like zolpidem, and some anticonvulsants target. Combining ashwagandha with these medications can amplify their sedative effects, increasing the risk of excessive drowsiness, impaired coordination, and respiratory depression in higher doses. Women who are already taking prescribed sleep aids or anti-anxiety medication in this class need to raise ashwagandha use with the prescribing doctor before starting, not as a formality but because the interaction is pharmacologically plausible.
The evidence for menopause-specific symptoms is promising but still limited
A small but growing number of trials have looked specifically at ashwagandha in menopausal women, with one randomised controlled trial finding that 300mg twice daily over eight weeks significantly reduced menopause symptom scores — including hot flushes, sleep disturbance, and mood — compared to placebo. The sample sizes are still modest and these are not the large-scale trials that support HRT recommendations, so ashwagandha sits firmly in the 'helpful addition for some women' category rather than a standalone treatment. Women with moderate to severe vasomotor symptoms in particular are unlikely to find it sufficient on its own and should explore the full range of evidence-based options.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.